LINEAGE INC
LINE · NASDAQ
Updated at 2026-10-14 11:07:53
- Today's High
- $34.89
- Today’s Low
- $34.16
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $34.29
- Previous Close
- $34.41
- Volume
- 1M
- Market Cap
- $7.83B
- P/E Ratio
- --
- EPS
- $-0.74
Previous Day Range
52-Week Range
Company Overview
- Sector
- REAL ESTATE
- Industry
- Real Estate
- Sub-industry
- REIT - INDUSTRIAL
- Headquarters
- 46500 HUMBOLDT DRIVE, NOVI, MI, UNITED STATES, 48377
- Country
- US
- Listing Date
- 2024-07-25
- Fiscal Year End
- December
- Shares Outstanding
- 227.67M
- CIK
- 0001868159
- Website
- www.onelineage.com
Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm dedicated to regenerative medicine, focusing on next-generation cell therapies targeting ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust strategic collaborations, Lineage is at the forefront of developing transformative treatment options that aim to improve patient outcomes significantly. The company's commitment to enhancing its diverse product pipeline and expediting clinical trials makes it an attractive investment opportunity for institutional investors seeking exposure in the rapidly evolving healthcare landscape.
Financial Metrics
Revenue
2026-06-30
$1.36B
2026-03-31
$1.29B
2025-12-31
$1.33B
2025-09-30
$1.37B
Operating Expenses
2026-06-30
$371M
2026-03-31
$141M
2025-12-31
-$603M
2025-09-30
$410M
Net Income
2026-06-30
-$29M
2026-03-31
-$46M
2025-12-31
$6M
2025-09-30
-$100M
Net Profit Margin
2026-06-30
-2.13%
2026-03-31
-3.54%
2025-12-31
0.44%
2025-09-30
-7.26%
Earnings Per Share
2026-06-30
$0.76
2026-03-31
$-0.15
2025-12-31
$0.19
2025-09-30
$0.85
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$291M
2026-03-31
$274M
2025-12-31
$579M
2025-09-30
$213M
Effective Tax Rate
2026-06-30
3.03%
2026-03-31
-8.51%
2025-12-31
175%
2025-09-30
-10.89%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $1.36B | $1.29B | $1.33B | $1.37B |
| Operating Expenses | $371M | $141M | -$603M | $410M |
| Net Income | -$29M | -$46M | $6M | -$100M |
| Net Profit Margin | -2.13% | -3.54% | 0.44% | -7.26% |
| Earnings Per Share | $0.76 | $-0.15 | $0.19 | $0.85 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $291M | $274M | $579M | $213M |
| Effective Tax Rate | 3.03% | -8.51% | 175% | -10.89% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.